Table 2:
Characteristics of patients undergoing surgery versus no surgery (N=229)
| Surgery (n = 117) | No Surgery (n = 112) | p-valuea | |
|---|---|---|---|
| Age (in years), median (IQR) | 58 (50-64) | 59 (48-67) | 0.457 |
| Female sex, n (%) | 58 (50) | 56 (50) | 0.948 |
| Self-reported weight loss, n (%) | 37 (36) | 16 (20) | 0.018 |
| Palpable abdominal mass, n (%) | 13 (11) | 18 (16) | 0.285 |
| Gastric outlet obstruction, n (%) | 39 (33) | 4 (3.5) | <0.001 |
| Symptom duration (in months), median (IQR) | 18 (8-36) | 12 (6-12) | 0.015 |
| Overall stage, n (%) Stage 1 Stage 2 Stage 3 Stage 4 |
5 (17.9) 7 (25.0) 6 (21.4) 10 (35.7) |
0 (0) 0 (0) 5 (25.0) 15 (75.0) |
0.004 |
| Tumor grade, n (%) Poorly differentiated Moderately differentiated Well differentiated |
19 (55.9) 6 (17.7) 9 (26.5) |
16 (57.1) 9 (32.1) 3 (10.7) |
0.200 |
| Tumor subtype, n (%) Diffuse Intestinal |
25 (50.0) 25 (50.0) |
24 (52.2) 22 (47.8) |
0.831 |
| Chemotherapy received, n (%) Neoadjuvant/palliative chemotherapy, n (%) |
25 (21.4) 12 (54.6) |
3 (2.7) 3 (100.0) |
<0.001 0.250 |
IQR: interquartile range
a
p-value less than 0.05 considered significant